SEC Form 4 · accession 0001140361-16-057138
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marvin L White
Director
Period of report
Mar 7, 2016
Accepted (ET)
Mar 9, 2016 · 3:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 7, 2016 | M | 10,800 | $15.75 | A | 41,100 | D | |
| Common StockF1,F6 | Mar 7, 2016 | S | 10,800 | $35.42 | D | 30,300 | D | |
| Common StockF2 | Mar 7, 2016 | M | 7,200 | $22.02 | A | 37,500 | D | |
| Common StockF2,F6 | Mar 7, 2016 | S | 7,200 | $35.42 | D | 30,300 | D | |
| Common StockF3 | Mar 7, 2016 | M | 7,200 | $14.66 | A | 37,500 | D | |
| Common StockF3,F6 | Mar 7, 2016 | S | 7,200 | $35.42 | D | 30,300 | D | |
| Common StockF4 | Mar 7, 2016 | M | 4,800 | $14.25 | A | 35,100 | D | |
| Common StockF4,F6 | Mar 7, 2016 | S | 4,800 | $35.42 | D | 30,300 | D | |
| Common StockF5 | Mar 7, 2016 | M | 3,134 | $20.44 | A | 33,434 | D | |
| Common StockF5,F6 | Mar 7, 2016 | S | 3,134 | $35.42 | D | 30,300 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1,F7 | $15.75 | Mar 7, 2016 | M | 10,800 | D | — | May 31, 2020 | Common Stock | 10,800 | 0 | D |
| Stock OptionsF2,F8 | $22.02 | Mar 7, 2016 | M | 7,200 | D | — | May 18, 2021 | Common Stock | 7,200 | 0 | D |
| Stock OptionsF3,F9 | $14.66 | Mar 7, 2016 | M | 7,200 | D | — | May 16, 2022 | Common Stock | 7,200 | 0 | D |
| Stock OptionsF4,F10 | $14.25 | Mar 7, 2016 | M | 4,800 | D | — | May 22, 2023 | Common Stock | 4,800 | 2,400 | D |
| Stock OptionsF5,F11 | $20.44 | Mar 7, 2016 | M | 3,134 | D | — | May 21, 2024 | Common Stock | 3,134 | 6,266 | D |
Explanation of responses
- F1Consists of an option granted under the company's stock incentive plan on June 1, 2010.
- F10The option vest in three equal installments in May 2014, 2015 and 2016.
- F11The option vest in three equal installments in May 2015, 2016 and 2017.
- F2Consists of an option granted under the company's stock incentive plan on May 19, 2011.
- F3Consists of an option granted under the company's stock incentive plan on May 17, 2012.
- F4Consists of an option granted under the company's stock incentive plan on May 23, 2013.
- F5Consists of an option granted under the company's stock incentive plan on May 22, 2014.
- F6The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.16 to $35.80, inclusive.
- F7The option vested in three equal installments in June 2011, 2012 and 2013.
- F8The option vested in three equal installments in May 2012, 2013 and 2014.
- F9The option vested in three equal installments in May 2013, 2014 and 2015.